Inactivated Influenza A H1N1pdm Virus (Oseltamivir-R)

Influenza A virus (H1N1pdm), a descendant of the 2009 pandemic strain (H1N1pdm09), is a highly contagious respiratory pathogen primarily transmitted through respiratory droplets, aerosols, and direct contact with contaminated surfaces. The virus targets epithelial cells of the upper and lower respiratory tracts, binding to sialic acid receptors via its hemagglutinin (HA) protein. Once inside the host, viral replication disrupts host cell function, triggering an inflammatory response manifested by fever, cough, sore throat, and, in severe cases, pneumonia or acute respiratory distress syndrome (ARDS). Oseltamivir-resistant strains (oseltamivir-R) harbor mutations in the neuraminidase (NA) gene, particularly the H275Y mutation (N1 numbering), which reduces drug binding affinity. This resistance complicates treatment, as the widely used nucleoside analog (NA) inhibitor oseltamivir gradually loses efficacy. Immunocompromised individuals and those with chronic medical conditions are at increased risk for severe illness and prolonged viral shedding, which promotes the emergence of resistant variants.

Influenza A (H1N1pdm) virus has a segmented, single-stranded, negative-sense RNA genome consisting of eight segments encoding 11 major proteins. The viral envelope is studded with two key glycoproteins: hemagglutinin (HA) and neuraminidase (NA), which determine the virus''s H1N1 subtype. Hemagglutinin mediates host cell attachment and membrane fusion, while neuraminidase facilitates viral release by cleaving sialic acid residues. The neuraminidase protein of the oseltamivir-R strain harbors the H275Y mutation, which alters its active site and reduces drug sensitivity. The viral RNA is encapsidated by the nucleoprotein (NP), which binds to the RNA-dependent RNA polymerase complex (PA, PB1, and PB2), which drives viral replication and transcription. The matrix protein (M1) is located beneath the viral envelope, while the ion channel protein (M2) facilitates viral uncoating. Nonstructural proteins (NS1 and NEP) regulate host immune responses and nuclear export of viral RNA. The segmented genome allows rapid antigenic shift through reassortment, thereby enhancing the evolutionary adaptability of the virus.